Erick DeVinney - Dec 27, 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: VP Peripheral Nerve Science
Signature: /s/Erick DeVinney
Stock symbol: AXGN
Transactions as of: Dec 27, 2022
Transactions value $: -$1,765
Form type: 4
Date filed: 12/29/2022, 07:56 PM
Previous filing: Jul 20, 2022
Next filing: Mar 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Options Exercise	$0	+750	+0.71%	$0.00	107K	Dec 27, 2022	Direct	F1
transaction	AXGN	Common Stock	Tax liability	-$1.77K	-187	-0.18%	$9.44	107K	Dec 27, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXGN	Restricted Stock Units	Options Exercise	$0	+750		$0.00^*	0	Dec 27, 2022	Common Stock	750		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This reflects the number of restricted stock units that vested on December 27, 2022.
F2	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F3	Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F4	All shares of AxoGen Inc. common stock underlying the restricted stock units vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter.